CEMI News and Press, Chembio Diagnostics Inc. From 07/01/20

Some Top Penny Stocks To Watch In Early July July is already off and running. Penny stocks haven’t stutter-stepped one bit. I know some people expected that if broad sector stocks took off, stocks under $5 would lose their luster. However, that hasn’t been the case at all. Some...

RADNOR, Pa., July 01, 2020 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds Chembio Diagnostics, Inc. (NASDAQ:  CEMI) (“Chembio”) investors that a securities fraud class action lawsuit has been filed in the United States District Court fo...

HAUPPAUGE, N.Y., July 01, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading global point-of-care diagnostic company focused on infectious diseases, today announced today that it will issue, after the U.S. financial markets close on Monday, July 6, 2020, ...

New York, New York--(Newsfile Corp. - June 25, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI) ("Chembio" or the "Company") of the August 17, 2020 deadline to seek the role of lead plaintiff in a federal se...

NEW YORK , June 25, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make fals...

NEW YORK , June 23, 2020 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Chembio Diagnostics, Inc. (NASDAQ: CEMI) common stock between March 12, 2020 and June 16, 2020 . On April 15, 2020 , Chembio announced it received a...

BioMarin Offers Additional Data for Valoctocogene Roxaparvovec Gene Therapy BioMarin Pharmaceutical Inc. ( BMRN ) provided an addendum to its previously announced four year update of an investigational gene therapy for treating severe hemophilia A. The study involved six patients who wer...

New York, New York--(Newsfile Corp. - June 18, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Chembio Diagnostics, Inc. (NASDAQ: CEMI) ("Chembio" or the "Company") of the August 17, 2020 deadline to seek the role of lead plaintiff in a federal se...

Gainers:  Cohen & Company (NYSEMKT: COHN ) +128% . More news on: Cohen & Company Inc., LM Funding America, Inc., Integrated Media Technology Limited, Stocks on the move, , Read more ...

Chembio Diagnostics (NASDAQ: CEMI )  -60%  after FDA yanks emergency use authorization of COVID-19 blood test. More news on: Chembio Diagnostics, Inc., BioCardia, Inc., Beasley Broadcast Group, Inc., Stocks on the move, , Read more ...